Manifestations of intraocular inflammation over time in patients on brolucizumab for neovascular AMD

Media type: E-Article
Title: Manifestations of intraocular inflammation over time in patients on brolucizumab for neovascular AMD
Contributor: Khoramnia, Ramin [Author]; Figueroa, Marta S. [Author]; Hattenbach, Lars-Olof [Author]; Pavésio, Carlos E. [Author]; Anderesi, Majid [Author]; Schmouder, Robert [Author]; Chen, Yu [Author]; de Smet, Marc D. [Author]
Published: 21 December 2021
Published in: Graefe's archive for clinical and experimental ophthalmology ; 260(2022), 6, Seite 1843-1856
Language: English
DOI: 10.1007/s00417-021-05518-0
Identifier:

Keywords: Anti-vascular endothelial growth factor ; Brolucizumab ; Intraocular inflammation ; Retinal vascular occlusion ; Retinal vasculitis
Origination:
Footnote:
Description: To describe the adverse events associated with brolucizumab, in particular the sequence of intraocular inflammation (IOI), retinal vasculitis (RV), and/or retinal vascular occlusion (RO).
Access State: Open Access

Search in field: